论文部分内容阅读
良性前列腺增生症(BPH)是老年男性的常见病。药物治疗主要为缩小前列腺体积和缓解症状[1]。目前,5α-还原酶抑制剂(5α-RI)和α1-受体阻滞剂(α1-AB)的疗效肯定,分别以非那甾胺和四喃唑嗪为代表。为评价单一与联合用药的疗效,我们分别对以上两种药物进行了疗效观察。在治疗BPH
Benign prostatic hyperplasia (BPH) is a common disease in older men. Drug treatment is mainly to reduce the size of the prostate and relieve symptoms [1]. At present, 5α-reductase inhibitors (5α-RI) and α1-blockers (α1-AB) have a positive effect, which are respectively represented by finasteride and doxazosin. To evaluate the efficacy of single and combination therapy, we observed the efficacy of the two drugs respectively. In the treatment of BPH